F-Star signs discovery pact with Merck Serono

Wednesday 7 September 2011

F-Star GmbH of Vienna will discover engineered antibodies for three inflammatory targets supplied by Merck Serono SA of Geneva in a contract that is potentially worth €492 million plus tiered royalties on product sales.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Austria